Premium
Dapoxetine: licensed treatment for premature ejaculation
Author(s) -
Chaplin Steve,
Mostyn Penny
Publication year - 2014
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.1189
Subject(s) - premature ejaculation , medicine , ejaculation , adverse effect , intensive care medicine , pharmacology , psychoanalysis , psychology
Dapoxetine (Priligy) is a new treatment for premature ejaculation licensed for as‐required use. In our New products review, Steve Chaplin presents the data relating to its efficacy and adverse events, and Dr Penny Mostyn discusses its place in therapy.